All Stories

  1. Lipid Oxidation Derived Aldehydes and Oxysterols Between Health and Disease
  2. Lipid Oxidation Products in the Pathogenesis of Inflammation-related Gut Diseases
  3. Relation between TLR4/NF‐κB signaling pathway activation by 27‐hydroxycholesterol and 4‐hydroxynonenal, and atherosclerotic plaque instability
  4. Inflammatory and redox reactions in colorectal carcinogenesis
  5. Cholesterol Oxidation Products in the Initiation, Progression, and Fate of Atherosclerotic Lesions
  6. The role of p38 MAPK in the induction of intestinal inflammation by dietary oxysterols: modulation by wine phenolics
  7. Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol
  8. Survival signaling elicited by 27-hydroxycholesterol through the combined modulation of cellular redox state and ERK/Akt phosphorylation
  9. Calorie Restriction and Dietary Restriction Mimetics: A Strategy for Improving Healthy Aging and Longevity
  10. Loading into Nanoparticles Improves Quercetin's Efficacy in Preventing Neuroinflammation Induced by Oxysterols
  11. Up‐regulation of β‐amyloidogenesis in neuron‐like human cells by both 24‐ and 27‐hydroxycholesterol: protective effect of N‐acetyl‐cysteine
  12. Wine consumption and intestinal redox homeostasis
  13. Inflammatory Bowel Disease: Mechanisms, Redox Considerations, and Therapeutic Targets
  14. Phenolic compounds present in Sardinian wine extracts protect against the production of inflammatory cytokines induced by oxysterols in CaCo-2 human enterocyte-like cells
  15. Evidence of cell damage induced by major components of a diet-compatible mixture of oxysterols in human colon cancer CaCo-2 cell line
  16. Oxysterols in the pathogenesis of major chronic diseases
  17. Oxidative stress in stable cystic fibrosis patients: Do we need higher antioxidant plasma levels?
  18. Molecular Signaling Involved in Oxysterol-Induced β1-Integrin Over-Expression in Human Macrophages
  19. Potentiation of amyloid-β peptide neurotoxicity in human dental-pulp neuron-like cells by the membrane lipid peroxidation product 4-hydroxynonenal
  20. Trend of key markers of macrophage-derived inflammatory mediators during colorectal tumor progression
  21. Alternate-day fasting reverses the age-associated hypertrophy phenotype in rat heart by influencing the ERK and PI3K signaling pathways
  22. Polyphenols from Sardinian red wine can modulate NOX1-dependent reactive oxygen species production in human enterocyte-like cells treated with a dietary mixture of oxysterols
  23. Progressive Increase of Matrix Metalloprotease-9 and Interleukin-8 Serum Levels during Carcinogenic Process in Human Colorectal Tract
  24. Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis
  25. New Insights into Redox-Modulated Cell Signaling
  26. Polyphenol Supplementation as a Complementary Medicinal Approach to Treating Inflammatory Bowel Disease
  27. Dietary lipids and their oxidized products in Alzheimer's disease
  28. Alternate-day fasting reverses the age-associated hypertrophy phenotype in rat heart by influencing the ERK and PI3K signaling pathways
  29. Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer’s disease: three partners in crime
  30. Proinflammatory effect of cholesterol and its oxidation products on CaCo-2 human enterocyte-like cells: effective protection by epigallocatechin-3-gallate
  31. An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples
  32. Xanthine oxidase-induced oxidative stress causes activation of NF-κB and inflammation in the liver of type I diabetic rats
  33. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma
  34. Inflammation-Related Gene Expression by Lipid Oxidation Derived Products in the Progression of Atherosclerosis
  35. Alternate-day fasting protects the rat heart against age-induced inflammation and fibrosis by inhibiting oxidative damage and NF-kB activation
  36. Pro-oxidant and proapoptotic effects of cholesterol oxidation products on human colonic epithelial cells: A potential mechanism of inflammatory bowel disease progression
  37. The core‐aldehyde 9‐oxononanoyl cholesterol increases the level of transforming growth factor β1‐specific receptors on promonocytic U937 cell membranes
  38. The contribution of animal fat oxidation products to colon carcinogenesis, through modulation of TGF- 1 signaling
  39. Oxidation as a crucial reaction for cholesterol to induce tissue degeneration: CD36 overexpression in human promonocytic cells treated with a biologically relevant oxysterol mixture
  40. 4-Hydroxynonenal–protein adducts: A reliable biomarker of lipid oxidation in liver diseases
  41. TGFβ1 expression in colonic mucosa: modulation by dietary lipids
  42. AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markers
  43. c-Jun N-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-β1 and 4-hydroxynonenal in colon mucosa
  44. Early Involvement of ROS Overproduction in Apoptosis Induced by 7-Ketocholesterol
  45. 4-Hydroxynonenal signalling to apoptosis in isolated rat hepatocytes: The role of PKC-δ
  46. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis
  47. Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells
  48. 4-Hydroxynonenal and TGF-β1 concur in inducing antiproliferative effects on the Caco-2 human colon adenocarcinoma cell line
  49. Role of 4-hydroxy-2,3-nonenal in the pathogenesis of fibrosis
  50. Oxidative Stress and Cell Signalling
  51. Trojan horse-like behavior of a biologically representative mixture of oxysterols
  52. 4-Hydroxynonenal is Markedly Higher in Patients on a Standard Long-term Home Parenteral Nutrition
  53. 4-Hydroxynonenal and transforming growth factor-β1 expression in colon cancer
  54. Down-modulation of nuclear localisation and pro-fibrogenic effect of 4-hydroxy-2,3-nonenal by thiol- and carbonyl-reagents
  55. Activation of PKC-β isoforms mediates HNE-induced MCP-1 release by macrophages
  56. Effect of perioperative infusion of antioxidants on neutrophil activation during liver transplantation in humans
  57. Physiological amounts of ascorbate potentiate phorbol ester-induced nuclear-binding of AP-1 transcription factor in cells of macrophagic lineage
  58. Glutathione depletion induces apoptosis of rat hepatocytes through activation of protein kinase C novel isoforms and dependent increase in AP-1 nuclear binding
  59. Regulation of rat hepatocyte protein kinase C ? isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: A signaling pathway to modulate vesicular transport of glycoproteins
  60. Liver AP-1 activation due to carbon tetrachloride is potentiated by 1,2-dibromoethane but is inhibited by α-tocopherol or gadolinium chloride
  61. Lipid Peroxidation in the Reperfusion Injury of the Liver
  62. Oxidative Damage and Reperfusion Syndrome in Human Liver Transplantation
  63. Neutrophil elastase and nitric oxide (NO) during ischemia-reperfusion and their relationships with sICAM-1 and antioxidants
  64. Biogenic 4-hydroxy-2-nonenal activates transcription factor AP-1 but not NF-κB in cells of the macrophage lineage
  65. Oxidative Damage and Transforming Growth Factor β1 Expression in Pretumoral and Tumoral Lesions of Human Intestine
  66. Reperfusion damage to the bile canaliculi in transplanted human liver
  67. Oxidative Stress and Cell Damage Following Orthotopic Liver Transplantation.
  68. In vivo potentiation of 1,2-dibromoethane hepatotoxicity by ethanol through inactivation of glutathione-s-transferase
  69. Cytolysis does not per se induce lipid peroxidation: Evidence in man
  70. Metabolism of 4-Hydroxy-2-nonenal and Aging
  71. Oxidative stress and tissue damage after human liver transplantation
  72. Oxidative stress in the development of human ischemic hepatitis during circulatory shock
  73. Ability of different hepatoma cells to metabolize 4-hydroxynonenal
  74. Change of liver metabolism of 1,2-dibromoethane during simultaneous treatment with carbon tetrachloride
  75. Rat hepatocytes in single cell suspension: A still suitable system for lipid peroxidation studies
  76. Vitamin E dietary supplementation protects against carbon tetrachloride—induced chronic liver damage and cirrhosis
  77. Lipid Peroxidation and Hepatocyte Damage in the Animal Model and in Human Patients
  78. Lipid peroxidation and irreversible cell damage: Synergism between carbon tetrachloride and 1,2-dibromoethane in isolated rat hepatocytes
  79. In vivo andin vitro evidence concerning the role of lipid peroxidation in the mechanism of hepatocyte death due to carbon tetrachloride
  80. POTENTIATION BY 1,2-DIBROMOETHANE OF LIPID PEROXIDATION AND IRREVERSIBLE HEPATOCYTE DAMAGE DUE TO CARBON TETRACHLORIDE
  81. Inactivation of hepatocyte Protein Kinase C by carbon tetrachloride: Involvement of drug's metabolic activation and prooxidant effect
  82. CCl4-induced increase of hepatocyte free arachidonate level: Pathogenesis and contribution to cell death
  83. Inactivation of hepatocyte protein kinase C by carbon tetrachloride: Involvement of drug's metabolic activation and prooxidant effect
  84. Potentiation by 1,2-dibromoethane of lipid peroxidation and irreversible hepatocyte damage due to carbon tetrachloride
  85. Lipid peroxidation and covalent binding in the early functional impairment of liver golgi apparatus by carbon tetrachloride
  86. Carbon Tetrachloride-Induced Oxidative Stress at the Level of Liver Golgi Apparatus: Effect on Lipoprotein Secretion
  87. Free Radical Mediated Liver Toxicity
  88. Lipid peroxidation in human diseases: Evidence of red cell oxidative stress after circulatory shock
  89. The CCl4-Induced Increase of Free Arachidonate in Hepatocytes
  90. Lipid Peroxidation and Irreversible Hepatocyte Damage
  91. Lipid Peroxidation and Haloalkylation in CCl4-Induced Liver Fatty Degeneration and Necrosis
  92. Pro-Hemolytic Effect of Aldehydic Products of Lipid Peroxidation
  93. Inhibition of Liver Golgi Glycosylation Activities by Carbonyl Products of Lipid
  94. Resistance to oxidative stress by hyperplastic and neoplastic rat liver tissue monitored in terms of production of unpolar and medium polar carbonyls
  95. New Data on Kinetics of Lipid Peroxidation in Experimental Hepatomas and Preneoplastic Nodules
  96. Mechanisms responsible for carbon tetrachloride-induced perturbation of mitochondrial calcium homeostasis
  97. Susceptibility and resistance of rat liver tissue to oxidative damage during diethylnitrosamine carcinogenesis
  98. Further Experiments on Lipid Peroxidation in Transplanted and Experimental Hepatomas
  99. Paracetamol-stimulated lipid peroxidation in isolated rat and mouse hepatocytes
  100. In vitro evidence for CCl4 metabolites covalently bound to lipoprotein micelles
  101. Biochemical evidence for chemical and/or topographic differences in the lipoperoxidative processes induced by CCl4 and iron
  102. Iron Overload: Experimental Approach Using Rat Hepatocytes in Single Cell Suspension